Ana Hidalgo-Simon – Head of Advanced Therapies, European…
The EMA’s Head of Advanced Therapies Dr Ana Hidalgo-Simon outlines Europe’s evolving regulatory framework for regenerative medicines, how it…
Tagged with Regulator
Post-Brexit UK Joins Australia, Canada, Singapore &…
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to leave the European Union, some…
Peter Marks – Director, Center for Biologics Evaluation and…
Dr Peter Marks MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), highlights…
EMA: Ireland’s Emer Cooke Set to Take the Helm
The European Medicines Agency (EMA), Europe’s regulatory body for medicines, has nominated Irish candidate Emer Cooke to as its new executive…
China’s Regulatory Reform and its Contribution to Global…
Song Ruilin, chairman of the China Pharmaceutical Innovation and Research Development Association (PhIRDA) highlights the leaps and bounds with which…
Hot Topics in Mexican Pharma
Earlier in 2020, PharmaBoardroom sat down with several key stakeholders in the Mexican healthcare and life sciences industry, from the leaders of…
Xavier De Cuyper – CEO, Belgian Federal Agency for…
Xavier De Cuyper introduces the Federal Agency for Medicines & Health Products (FAMHP) and the essential role it plays in Belgium’s healthcare…
Maggie De Block – Minister of Social Affairs, Public Health…
Belgian Minister of Social Affairs, Public Health and Asylum & Migration Maggie de Block outlines some of the key reforms her Ministry has rolled…
Dan Zaharescu – Executive Director, ARPIM, Romania
Dan Zaharescu, executive director of the Romanian Association of Pharmaceutical Manufacturers (ARPIM), shares his insights on market access, the need…
Barbara Lopez Kunz – CEO, Drug Information Association…
Barbara Lopez Kunz, CEO of the Drug Information Association (DIA) in the USA, outlines the association’s four key areas of focus – regulatory…
Janet Woodcock – Director, Center for Drug Evaluation and…
In an exclusive interview, Janet Woodcock, head of the Center for Drug Evaluation and Research (CDER) at the US Food & Drug Administration (FDA)…
Chilean Healthcare Reform: “Deep & Comprehensive” but…
Against a backdrop of protests against Chile’s market-dominant socio-economic model, President Sebastián Piñera has announced a wave of reforms to…
